Sign Up to like & get recommendations! 1
Published in 2021 at "Indian Heart Journal"
DOI: 10.1016/j.ihj.2021.07.007
Abstract: Pulmonary arterial hypertension (PAH) - a complex and progressive disease that carries significant morbidity and mortality despite optimal medical treatment. Combination therapy for PAH can be more effective than monotherapy. The present randomized trial compared… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2021.03.033
Abstract: BACKGROUND Eisenmenger syndrome (ES) comprises a severe phenotype of pulmonary arterial hypertension characterized by angiopathy of the lung circulation. The aim of the present study was to demonstrate the presence of systemic microvascular abnormalities in… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Respiratory Medicine Case Reports"
DOI: 10.1016/j.rmcr.2017.03.002
Abstract: Eisenmenger syndrome (ES) is the most severe form of pulmonary arterial hypertension (PAH) associated with congenital heart disease. It is an extremely devastating condition with a serious impact on patients' life. Classical therapy of ES… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(19)32909-2
Abstract: Two defining features of Eisenmenger syndrome are “severely increased” and “irreversible” pulmonary vascular resistance as a result of uncorrected large left to right shunt. It is important to distinguish it from other causes of pulmonary… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Cardiology in the young"
DOI: 10.1017/s1047951122004152
Abstract: BACKGROUND Despite advances in medical care, we still come across pregnancy in Eisenmenger syndrome. Eisenmenger syndrome represents the severe end of the spectrum for disease in pulmonary artery hypertension associated with CHD. Due to very… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2021-245549
Abstract: Eisenmenger syndrome (ES) is the most severe form of pulmonary arterial hypertension and is associated with congenital heart disease. ES itself is a challenging condition to manage, further compounded if the patient is critically ill… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Heart"
DOI: 10.1136/heartjnl-2016-310979
Abstract: Objective Improved diagnostic tools, timely closure of the shunt and a better understanding of the complexity of Eisenmenger syndrome (ES) have led to improved care and treatment in tertiary centres. These may have decreased the… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Heart"
DOI: 10.1136/heartjnl-2017-311396
Abstract: In 1897, Dr Victor Eisenmenger described a 32-year-old man with a history of cyanosis and progressive exertional breathlessness since childhood. The patient developed heart failure in his 30s and, thereafter, died suddenly following massive haemoptysis.… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Heart"
DOI: 10.1136/heartjnl-2017-311876
Abstract: Objective Eisenmenger syndrome (ES) is a severe form of pulmonary hypertension in adults with congenital heart disease (CHD) and has a poor prognosis. We aimed to understand factors associated with survival in ES and particularly… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Heart"
DOI: 10.1136/heartjnl-2017-312215
Abstract: When Viktor Eisenmenger first described (1897) and later Paul Wood (1958) expanded on the Eisenmenger syndrome (ES), the options of treatment of this condition were very limited. The pulmonary hypertension (PH) associated with this condition… read more here.